2019-2023年河北省某三甲医院临床分离主要病原菌及耐药性分析

Analysis on major clinical pathogenic isolatesand their drug resistance in a grade Ⅲ (A) hospital in Hebei, 2019−2023

  • 摘要:
    目的  了解2019-2023年河北医科大学第二医院临床分离鉴定的病原菌及耐药情况,为本院临床抗菌药物的合理应用提供依据。
    方法 应用WHONET 5.6软件对2019年1月至2023年12月河北医科大学第二医院临床分离的病原菌和耐药相关数据进行分析,采用SPSS 27.0软件进行统计分析。
    结果 剔除重复菌后,2019-2023年河北医科大学第二医院共分离临床病原菌81000株,革兰阴性菌64953株(80.19%),革兰阳性菌16047株(19.81%)。革兰阴性菌检出前3位病原菌依次为肺炎克雷伯菌、鲍曼不动杆菌、铜绿假单胞菌;革兰阳性菌检出前3位为金黄色葡萄球菌、屎肠球菌、表皮葡萄球菌。病原菌主要来源于痰液(57.46%)、尿液(11.66%)和血液(9.39%);分离菌株数量最多的科室为呼吸内科,其次为重症医学科和神经外科。肺炎克雷伯菌对亚胺培南、美罗培南及氨基糖苷类抗菌药物总体保持较高敏感性,耐药率为15.51~33.2%。鲍曼不动杆菌对碳青霉烯类耐药率为49.09%~78.30%,铜绿假单胞菌对碳青霉烯类耐药率为18.44%~37.21%,大肠埃希菌对碳青霉烯类耐药率较低,仅为1.75%~6.30%。在金黄色葡萄球菌中,除复方新诺明和庆大霉素外,耐甲氧西林金黄色葡萄球菌对其他多种抗菌药物的耐药率均高于甲氧西林敏感金黄色葡萄球菌。2019-2023年,耐碳青霉烯类鲍曼不动杆菌和耐碳青霉烯类大肠埃希菌检出率呈上升趋势。
    结论 2019-2023年该院临床分离病原菌以革兰阴性菌为主,且呈现地域特征。多重耐药菌有上升趋势,医院应持续加强病原菌耐药性监测和抗菌药物合理使用,以减少多重耐药菌的产生。

     

    Abstract:
    Objective To understand the distribution of clinical pathogenic isolates and their drug resistances in the Second Hospital of Hebei Medical University from 2019 to 2023, and provide evidence for the rational use of antibiotics in clinical practice.
    Methods Data on clinical pathogen isolates and their drug resistance pattern in the hospital between January 2019 and December 2023 were analyzed by using WHONET 5.6 software, and statistical analysis on the results were performed by using SPSS 27.0.
    Results After exclusion of duplicate isolates, a total of 81 000 0 clinical pathogenic isolates were collected from the hospital between 2019 and 2023, in which 64 953 (80.19%) were gram-negative bacterial strains and 16 047 (19.81%) were gram-positive bacterial strains. The three most common Gram-negative pathogens were Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, whereas the three most common gram-positive pathogens were Staphylococcus aureus, Enterococcus faecium, and Staphylococcus epidermidis. Most isolates were isolated from sputum (57.46%), followed by urine (11.66%) and blood (9.39%). The isolation rate of the pathogens was highest in Respiratory Medicine Department, followed by the Intensive Care Unit and the Neurosurgery Department. K. pneumoniae was highly sensitive to imipenem, meropenem, and aminoglycosides, with an average resistance rate ranged from 15.51 to 33.2%. The resistance rates of A. baumannii to carbapenems ranged from 49.09% to 78.30%, whereas P. aeruginosa exhibited carbapenem resistance rates ranging from 18.44% to 37.21%. E. coli showed low resistance to carbapenems, with rates ranging from 1.75% to 6.30%. In the S. aureus isolates, methicillin-resistant S. aureus showed higher resistance rates to multiple antibiotics compared with methicillin-sensitive S. aureus with the exception of trimethoprim–sulfamethoxazole and gentamicin. From 2019 to 2023, the detection rates of carbapenem-resistant A. baumannii and carbapenem-resistant E. coli showed significant increase trends.
    Conclusion Between 2019 and 2023, gram-negative bacteria predominated in clinical pathogens isolated in this hospital, reflecting distinct regional epidemiological characteristics. The increased isolation of multidrug-resistant organisms underscores the need for continuous antibiotic resistance surveillance and the rational use of antibiotics to curb the spread of multidrug-resistant bacteria.

     

/

返回文章
返回